Anika Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Anika Therapeutics (ANIK) Tops Q1 EPS by 17c
April 27, 2016 4:06 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.45, $0.17 better than the analyst estimate of $0.28. Revenue for the quarter came in at $22.3 million versus the consensus estimate of $19.26 million.
We are off to a strong start in 2016, with total revenue growth of 44% year-over-year... More
